These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies. Spasova MI, Grudeva-Popova JG, Kostyanev SS, Genev ED, Stoyanova AA, Kirina VI, Moumdjiev IN. J BUON; 2009; 14(3):411-8. PubMed ID: 19810131 [Abstract] [Full Text] [Related]
4. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients. Baskaran ND, Gan GG, Adeeba K. Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382 [Abstract] [Full Text] [Related]
5. Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study. Offidani M, Corvatta L, Malerba L, Marconi M, Bichisecchi E, Cecchini S, Manso E, Principi T, Gasparini S, Leoni P. Cancer; 2004 Aug 01; 101(3):567-77. PubMed ID: 15274070 [Abstract] [Full Text] [Related]
6. [Prognostic risk factors for serious complications in an inpatient population with neutropenia at the onset of a febrile episode]. Gómez Roca C, Rivero M, Hugo K, Novillo A, Marta Lapadula M, Recondo G, Milberg M. Medicina (B Aires); 2006 Aug 01; 66(5):385-91. PubMed ID: 17137166 [Abstract] [Full Text] [Related]
8. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Vekemans M, Robinson J, Georgala A, Heymans C, Muanza F, Paesmans M, Klastersky J, Barette M, Meuleman N, Huet F, Calandra T, Costantini S, Ferrant A, Mathissen F, Axelsen M, Marchetti O, Aoun M. Clin Infect Dis; 2007 Jun 15; 44(12):1593-601. PubMed ID: 17516403 [Abstract] [Full Text] [Related]
9. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever. Chayakulkeeree M, Thamlikitkul V. J Med Assoc Thai; 2003 Mar 15; 86(3):212-23. PubMed ID: 12757060 [Abstract] [Full Text] [Related]
10. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies. Cherif H, Björkholm M, Engervall P, Johansson P, Ljungman P, Hast R, Kalin M. Scand J Infect Dis; 2004 Mar 15; 36(8):593-600. PubMed ID: 15370671 [Abstract] [Full Text] [Related]
11. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia. Ghalaut PS, Sen R, Dixit G. J Assoc Physicians India; 2008 Dec 15; 56():942-4. PubMed ID: 19322972 [Abstract] [Full Text] [Related]
12. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation. Ortega M, Rovira M, Almela M, de la Bellacasa JP, Carreras E, Mensa J. Bone Marrow Transplant; 2004 Apr 15; 33(7):741-4. PubMed ID: 14730343 [Abstract] [Full Text] [Related]
13. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia. Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G. Ann Hematol; 2007 Apr 15; 86(4):263-70. PubMed ID: 17225113 [Abstract] [Full Text] [Related]
14. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. Oude Nijhuis C, Kamps WA, Daenen SM, Gietema JA, van der Graaf WT, Groen HJ, Vellenga E, Ten Vergert EM, Vermeulen KM, de Vries-Hospers HG, de Bont ES. J Clin Oncol; 2005 Oct 20; 23(30):7437-44. PubMed ID: 16234511 [Abstract] [Full Text] [Related]
15. Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer? Maione P, Rossi A, Di Maio M, Gridelli C. Lung Cancer; 2009 Oct 20; 66(1):8-14. PubMed ID: 19328587 [Abstract] [Full Text] [Related]
16. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration]. Karthaus M, Südhoff T, Fenchel K, Egerer G, Kämpfe D, Ritter J, Franke A, Heil G, Peters G, Jürgens H. Wien Med Wochenschr; 1998 Oct 20; 148(21):481-7. PubMed ID: 10048176 [Abstract] [Full Text] [Related]
17. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma. Lyman GH, Delgado DJ. Cancer; 2003 Dec 01; 98(11):2402-9. PubMed ID: 14635075 [Abstract] [Full Text] [Related]
18. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever. McMeekin DS, Gazzaniga C, Berman M, DiSaia P, Manetta A. Gynecol Oncol; 1996 Aug 01; 62(2):247-53. PubMed ID: 8751557 [Abstract] [Full Text] [Related]
19. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia. Choi CW, Sung HJ, Park KH, Yoon SY, Kim SJ, Oh SC, Seo JH, Kim BS, Shin SW, Kim YH, Kim JS. Am J Hematol; 2003 Aug 01; 73(4):263-6. PubMed ID: 12879430 [Abstract] [Full Text] [Related]
20. Malaria parasitemia associated with febrile neutropenia in African patients undergoing chemotherapy for haematological malignancies. A report of three patients. Rapoport BL, Uys A. Chemotherapy; 2008 Aug 01; 54(2):117-9. PubMed ID: 18303260 [Abstract] [Full Text] [Related] Page: [Next] [New Search]